Highly potent dipeptidyl peptidase IV inhibitors derived from Alogliptin through pharmacophore hybridization and lead optimization-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Highly potent dipeptidyl peptidase IV inhibitors derived from Alogliptin through pharmacophore hybridization and lead optimization

Published:2013-10 Issue: Volume:68 Page:312-320
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Xie Hui,Zeng Lili,Zeng Shaogao,Lu Xin,Zhao Xin,Zhang Guicheng,Tu Zhengchao,Xu Hongjiang,Yang Ling,Zhang Xiquan,Wang Shanchun,Hu Wenhui

Funder

Bureau of Science and Technology of Guangzhou Municipality

Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference23 articles.

1. Type 2 diabetes comorbidities and treatment challenges: rationale for DPP-4 inhibitors;Hollander;Postgraduate Medicine,2010

2. Glucagon-like peptide-1 7-36: a physiological incretin in man;Kreymann;Lancet,1987

3. DPP-4 inhibitors;Ahren;Best Practice & Research: Clinical Endocrinology & Metabolism,2007

4. A new therapeutic possibility for type 2 diabetes: DPP-4 inhibitors (sitagliptin);Abel;Orvosi Hetilap,2010

5. Glucagon-like peptide-1: a basis for new approaches to the management of diabetes;Deacon;Drugs of Today (Barcelona, Spain),1999

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of the selective and nanomolar inhibitor of DPP-4 more potent than sitagliptin by structure-guided rational design;European Journal of Medicinal Chemistry;2024-12

2. Formation of quinazolin-4(3H)-ones from N-sulfonoketenimines and 2-aminobenzamides;Journal of the Iranian Chemical Society;2024-02-03

3. Development of Long-Acting Dipeptidyl Peptidase-4 Inhibitors: Structural Evolution and Long-Acting Determinants;Journal of Medicinal Chemistry;2023-08-30

4. A novel artificial intelligence protocol to investigate potential leads for diabetes mellitus;Molecular Diversity;2021-03-09

5. Structural optimization of pyrazolo[1,5-a]pyrimidine derivatives as potent and highly selective DPP-4 inhibitors;European Journal of Medicinal Chemistry;2020-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3